Antibacterial prophylaxis in endourological procedures;La profilassi antibatterica nelle manovre endourologiche

Minerva Urologica e Nefrologica

Volumn 58, Issue 1, 2006, Pages 73-80

  Prezioso, D ^a,e   Bartoletti, R ^b   Damiano, R ^c   Morgia, G ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

^e FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

Ciprofloxacin; Endoscopic instrumentation; Levofloxacin; Prulifloxacin

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN; CIPROFLOXACIN; FOSFOMYCIN TROMETAMOL; LEVOFLOXACIN; METRONIDAZOLE; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; ARTICLE; BLADDER CATHETERIZATION; CLINICAL FEATURE; CONTROLLED STUDY; CYSTOSCOPY; DEMOGRAPHY; DRUG USE; ENDOUROLOGY; EXTRACORPOREAL LITHOTRIPSY; FEMALE; GRAM NEGATIVE BACTERIUM; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PATIENT COMPLIANCE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PROSTATE BIOPSY; RISK FACTOR; SURGICAL RISK; URINARY TRACT INFECTION; URINE CULTURE; UROLOGIC SURGERY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; BIOPSY; CYSTOSCOPY; FEMALE; HUMANS; LITHOTRIPSY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTATE; URINARY CATHETERIZATION; UROLOGIC SURGICAL PROCEDURES;

EID: 33744970496     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. De Lalla F. Profilassi antibiotica dell'infezione postoperatoria. In: De Lalla F editor. L'infezione postoperatoria. Pavia: Edimes; 2003.p.95-112.
2. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999;27:97-132.
3. Larsen EH, Gasser TC, Madsen PO. Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am 1986;13:591-604.
4. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002;113 Suppl 1A:5S-13S.
5. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG, Hardison CD et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. AmJ Med 1981;70:947-59.
6. Arpi M, Werner C, Timmermann B. Bacteremia following transurethral instrumentation. The predictive value of a serum bactericidal activity test. Scand J Urol Nephrol 1986;20:169-76.
7. Prescott S, Hadi MA, Elton RA, Ritchie AW, Foubister GC, Gould JC et al. Antibiotic compared with antiseptic prophylaxis for prostatic surgery. Br J Urol 1990;66:509-14.
8. Islam MA, Shameem IA, Ahasan DN, Choudhury GM, Wahab MA. Necessity of antibiotics prophylaxis during extracorporeal shock wave lithotripsy. Mymensingh Med J 2005;14:58-60.
9. Pettersson B, Tiselius HG. Are prophylactic antibiotics necessary during extracorporeal shockwave lithotripsy? Br J Urol 1989;63:449-52.
10. Pearle MS, Roehrborn CG. Antimicrobial prophylaxis prior to shock wave lithotripsy in patients with sterile urine before treatment: a meta-analysis and cost-effectiveness analysis. Urology 1997;49:679-86.
11. Thompson PM, Pryor JP, Williams JP, Eyers DE, Dulake C, Scully MF et al. The problem of infection after prostatic biopsy: the case for the transperineal approach. Br J Urol 1982;54:736-40.
12. Gustafsson O, Norming U, Nyman CR, Ohstrom M. Complications following combined transrectal aspiration and core biopsy of the prostate. Scand J Urol Nephrol 1990;24:249-51.
13. Torp-Pedersen S, Lee F, Littrup PJ, Siders DB, Kumasaka GH, Solomon MH et al. Transrectal biopsy of the prostate guided with transrectal US: longitudinal and multiplanar scanning. Radiology 1989;170(1 Pt 1):23-7.
14. Enlund AL, Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol 1997;79:777-80.
15. Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 2001;166:856-60.
16. Puig J, Darnell A, Bermudez P, Malet A, Serrate G, Bare M et al. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary? Eur Radiol 2006;19:939-43.
17. Sabbagh R, McCormack M, Peloquin F, Faucher R, Perreault JP, Perrotte P et al. A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can J Urol 2004;11:2216-9.
18. Sieber PR, Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Harpster LE. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 1997;157:2199-200.
19. Aus G, Ahlgren G, Bergdahl S, Hugosson J. Infection after transrectal core biopsies of the prostate-risk factors and antibiotic prophylaxis. Br J Urol 1996;77:851-5.
20. Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 1998;160(6 Pt 1):2115-20.
21. Veliev EI. Antibacterial prophylaxis of bacteriuria at transrectal multifocal prostatic biopsy. Antibiot Khimioter 2002;47:3-5.
22. Cormio L, Berardi B, Callea A, Florentine N, Sblendorio D, Zizzi V et al. Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU Int 2002;90:700-2.
23. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 2000;85:682-5.
24. Isen K, Kupeli B, Sinik Z, Sozen S, Bozkirli I. Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim- sulfamethoxazole. Int Urol Nephrol 1999;31:491-5.
25. Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998;52:552-8.
26. Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 2002;168:1021-3.
27. Tobias-Machado M, Correa TD, De Barros EL, Wroclawski ER. Antibiotic prophylaxis in prostate biopsy. A comparative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol. Int Braz J Urol 2003;29:313-9.
28. Trinchieri A, Mangiarotti B, Lizzano R. Use of levofloxacin in the antibiotic prophylaxis for diagnostic procedures in urology. Arch Ital Urol Androl 2002;74:33-9.
29. Naber KG, Hofstetter AG, Bruhl P, Lebert C. Leitlinier zur perioperative prophylaxe nel eingriffen an den hernwegen und im mannlichen genitalbereich. Chemother J 2000;9:165-70.
30. Keam SJ, Perry CM. Prulifloxacin. Drugs. 2004;64:2221-34; discussion 2235-6.
31. Montanari MP, Mingoia M, Varaldo PE. In vitro antibacterial activities of AF3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates. Antimicrob Agents Chemother 2001;45:36l6-22.
32. Prats G, Roig C, Mirò E, Navarro F, Mirelis B. In vitro activity of AF3013, the active metabolite of prulifloxacin: a comparison with other fluoroquinolones. Eur J Microbiol Infect Dis 2002;21:328-34.
33. Picollo R, Brion N, Gualano V, Millerioux L, Marchetti M, Rosignoli MT et al. Pharmacokinetics and tolerability of prulifloxacin after single oral administration. Arzneimittelforschung 2003;53:201-5.
34. Matera MG. Pharmacologic characteristics of prulifloxacin. Pulm Pharmacol Ther 2006;19 Suppl 1:20-9.
35. Suzuki K, Masaki H, Ishikawa K et al. Basic and clinical studies on NM441 in chronic bacterial prostatitis. Jpn J Chemother 1996;44:405-13.
36. Carmignani G, De Rose AF, Olivieri L, Salvatori E, Rosignoli MT, Dionisio P. Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections. Urol Int 2005;74:326-31.
37. Pomara G, Dicuio M, Romano G, Campo G, Paperini D, Mogorovich A et al. Efficacia di ciprofloxacina e prulifloxacina nella prevenzione delle complicanze infettive in corso di mapping prostatico bioptico. Risultati di un primo studio multicentrico, randomizzato in doppio cieco. XV Congresso Nazionale Società Italiana di Urologia Oncologica, Giardini Naxos, 3-6 Novembre 2005.